Eli Lilly's plans to build a multibillion-dollar drug research facility in Indiana is expected to help establish a regional biotechnology hub that strengthens the country's biotech supply chain.
Eli Lilly's plans to build a multibillion-dollar drug research facility in Indiana is expected to help establish a regional biotechnology hub that strengthens the country's biotech supply chain.
Watch the video to learn how you can access industry leading CRE news and the data analytics you need to drive success.
This news story is available exclusively to CoStar subscribers.
Ready to Learn More?
Sign Up For a Personalized Demo.
Sign Up For a Demo To Learn More.
Already A Subscriber? Sign In